Month: September 2022

Sep 08 2022

Uncategorized

Understanding the symptoms of schizophrenia

by Clinical Editor

No Comments

Schizophrenia is a mental health condition that usually appears in late adolescence or early adulthood. Its impact on speech, thinking, emotions, and other areas of life can affect a person’s...

Sep 08 2022

Uncategorized

Scientists Have Identified a Brain Cell That Makes Humans Special. But It Also Leaves us Vulnerable to Schizophrenia, Autism, and Epilepsy.

by Clinical Editor

No Comments

Although it’s been studied for centuries, the human brain is still largely a mystery to scientists. They don’t fully understand what causes many conditions of the brain, from depression to...

Sep 07 2022

Uncategorized

Clinical Overview: Treatment of Schizophrenia, Schizoaffective Disorders – Pharmacy Times

by Clinical Editor

No Comments

Clinical Overview: Treatment of Schizophrenia, Schizoaffective Disorders  Pharmacy Times

Sep 07 2022

Uncategorized

Scientists Have Identified a Brain Cell That Makes Humans Special. But It Also Leaves us Vulnerable to Schizophrenia, Autism, and Epilepsy.

by Clinical Editor

No Comments

Although it’s been studied for centuries, the human brain is still largely a mystery to scientists. They don’t fully understand what causes many conditions of the brain, from depression to...

Sep 07 2022

Uncategorized

What are the best medications for schizophrenia?

by Clinical Editor

No Comments

Schizophrenia is a serious mental health condition that requires lifelong treatment to manage. However, with proper medications, a person can live a fulfilling life. Doctors typically use a class …

Sep 07 2022

Uncategorized

Schizophrenia Epidemiology Analysis and Forecast, 2021-2031

by Clinical Editor

No Comments

New York, Sept. 05, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Schizophrenia Epidemiology Analysis and Forecast, 2021-2031” – https://www.reportlinker.com …

Sep 07 2022

Uncategorized

Study of injection to treat schizophrenia to begin after $3M payment received

by Clinical Editor

No Comments

A phase 3 clinical trial for an injection to treat patients with schizophrenia has been initiated by MedinCell and Teva Pharmaceuticals.

Sep 07 2022

Uncategorized

Challenging the standard paradigm of schizophrenia research

by Clinical Editor

No Comments

Analyzing EEG measurements of almost two hundred schizophrenia patients and healthy controls, researchers at EPFL now challenge the standard paradigm underlying research in the field …

Sep 06 2022

Uncategorized

Schizophrenia Epidemiology Analysis and Forecast, 2021-2031 – GlobeNewswire

by Clinical Editor

No Comments

Schizophrenia Epidemiology Analysis and Forecast, 2021-2031  GlobeNewswire

Sep 06 2022

Uncategorized

Schizophrenia Epidemiology Analysis and Forecast, 2021-2031

by Clinical Editor

No Comments

Summary Schizophrenia is a chronic and debilitating mental illness, characterized by delusions, hallucinations, disorganized speech, trouble with thinking, and a lack of motivation.New York, Sept. 05, …